This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Collen, D. Articles by Lijnen, H. R. Search for Related Content PubMed PubMed Citation Articles by Collen, D. Articles by Lijnen, H. R.

Circulation, Vol 72, 384-388, Copyright © 1985 by American Heart Association

ARTICLES

Coronary thrombolysis in dogs with intravenously administered human pro- urokinase

D Collen, D Stump, F van de Werf, IK Jang, M Nobuhara and HR Lijnen

Coronary thrombolysis was induced by infusion of highly purified human pro-urokinase isolated from a transformed kidney cell line (ACHN) or by infusion of urokinase of urinary origin in anesthetized dogs with 1-hr- old clots in the left anterior descending coronary artery. The clots were induced with a copper coil and thrombolysis was detected by repeat coronary angiography. Intravenous infusion of pro-urokinase at a rate of 10 micrograms/kg/min for 30 min in two dogs did not induce thrombolysis, which was only obtained after 8 and 15 min of its subsequent intracoronary administration. Intravenous infusion of pro- urokinase at a rate of 20 micrograms/kg/min for 30 min in four dogs induced coronary thrombolysis within 23 +/- 2 min (mean +/- SEM). This was not associated with systemic fibrinolytic activation because the alpha 2-antiplasmin and fibrinogen levels did not decrease. Intravenous infusion of urokinase at a rate of 10 micrograms/kg/min for 30 min elicited thrombolysis in four of seven dogs within an average of 19 +/- 2 min. In the other three dogs thrombolysis was only obtained within 11 +/- 3 min of its subsequent intracoronary infusion. Administration of urokinase was associated with systemic fibrinolytic activation as evidenced by a decrease of alpha 2-antiplasmin to about 10% and of fibrinogen to 43 +/- 13% of the preinfusion value. It is concluded that intravenous infusion of pro-urokinase at a sufficiently high rate produces coronary thrombolysis without systemic fibrinolysis in dogs.

This article has been cited by other articles:

				J.-N. Liu, J.-X. Liu, B.-f. Liu, Z. Sun, J.-L. Zuo, P.-x. Zhang, J. Zhang, Y.-h. Chen, and V. Gurewich Prourokinase Mutant That Induces Highly Effective Clot Lysis Without Interfering With Hemostasis Circ. Res., April 19, 2002; 90(7): 757 - 763. [Abstract] [Full Text] [PDF]

				L.-P. Lai, J.-L. Lin, W.-P. Lien, Y.-Z. Tseng, and S. K. S. Huang Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of the electrophysiological effects by biatrial basket electrodes J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1434 - 1441. [Abstract] [Full Text] [PDF]

				E. J. Harris JR and J. M. Porter Thrombolytic Therapy and Modern Vascular Surgery: An Overview Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1989; 2(2): 40 - 63. [PDF]

				M. A. Sloan Thrombolysis and Stroke: Past and Future Arch Neurol, July 1, 1987; 44(7): 748 - 768. [Abstract] [PDF]

				P. L. Zwerner and J. M. Gore Analytic Review: Thrombolytic Therapy in Acute Myocardial Infarction J Intensive Care Med, December 1, 1986; 1(6): 302 - 318. [Abstract] [PDF]

				F. VAN DE WERF, M. NOBUHARA, and D. COLLEN Coronary Thrombolysis with Human Single-Chain, Urokinase-Type Plasminogen Activator (Pro-Urokinase) in Patients with Acute Myocardial Infarction Ann Intern Med, March 1, 1986; 104(3): 345 - 348. [Abstract] [PDF]

				D.C. Stump, H.R. Lijnen, and D. Collen Biochemical and Biological Properties of Single-chain Urokinase-type Plasminogen Activator Cold Spring Harb Symp Quant Biol, January 1, 1986; 51(0): 563 - 569. [Abstract] [PDF]

				J.-N. Liu, J.-X. Liu, B.-f. Liu, Z. Sun, J.-L. Zuo, P.-x. Zhang, J. Zhang, Y.-h. Chen, and V. Gurewich Prourokinase Mutant That Induces Highly Effective Clot Lysis Without Interfering With Hemostasis Circ. Res., April 19, 2002; 90(7): 757 - 763. [Abstract] [Full Text] [PDF]